Harmony Biosciences Holdings Inc’s recent filing unveils that its Former Officer JEFFREY G DIERKS acquired Company’s shares for reported $0.2 million on Jun 10 ’25. In the deal valued at $35.98 per share,5,615 shares were bought.
Then, JEFFREY G DIERKS bought 9,844 shares, generating $350,083 in total proceeds.
Before that, JEFFREY G DIERKS bought 2,292 shares. Harmony Biosciences Holdings Inc shares valued at $80,427 were divested by the Former Officer at a price of $35.09 per share.
Truist initiated its Harmony Biosciences Holdings Inc [HRMY] rating to a Buy in a research note published on July 21, 2025; the price target was $48. Deutsche Bank started covering the stock on February 11, 2025. It rated HRMY as “a Buy”.
Price Performance Review of HRMY
On Monday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock jump 0.14% to $35.25. Over the last five days, the stock has gained 1.56%. Harmony Biosciences Holdings Inc shares have risen nearly 6.56% since the year began. Nevertheless, the stocks have risen 2.44% over the past one year.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2025-06-13, growing by 1.15 million shares to a total of 3.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.55 million shares. There was a rise of 31.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 17, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $75 price target.